News Center

News Center

News Center

News Center

2021-10-19

[Science Popularization Time] Companion Diagnostics — The Booster for Tumor Immunotherapy

[Science Popularization Time] Companion Diagnostics — The Booster for Tumor Immunotherapy

Tumor prevention and treatment have always been a key focus in medical development. Especially since the 20th century, through decades of relentless efforts in the scientific and industrial communities, multiple approaches such as surgery, radiotherapy, chemotherapy, and targeted therapy have been widely developed, improving the survival time and quality of life for some tumor patients. However, treating malignant tumors remains challenging. It is only in recent years that immunotherapy, which mobilizes the body's immune system to suppress or even eliminate tumors, has made breakthrough progress. This approach has shown promising therapeutic prospects in various tumors, significantly inhibiting tumor growth and extending patient survival, bringing a revolutionary breakthrough to tumor treatment.
Learn More Details

2021-09-15

[Science Popularization Time] Early Cancer Screening — An Important Part of Physical Examination

[Science Popularization Time] Early Cancer Screening — An Important Part of Physical Examination

Due to the hidden nature of early tumor symptoms, by the time obvious symptoms appear, the patient's chances of survival have often significantly decreased. For example, early-stage gastric cancer patients experience varying degrees of digestive tract or stomach symptoms, such as upper abdominal discomfort, dull pain, bloating, and fatigue. These symptoms are often ignored because patients "endure" them or think they are due to a lack of appetite, weather, or mood. This has objectively led to 90% of gastric cancer patients only seeking medical attention at the middle or late stages. However, if detected early and treated promptly with standardized therapy, the cure rate for early gastric cancer exceeds 90%.
Learn More Details
< 1...24252627 >